Abstract
Amyloid peptides (Aβ) are fragments of the Amyloid Precursor Protein (APP), an integral membrane protein. Aβ peptides are continuously generated by neurons and non-neuronal cells via sequential cleavage of APP by secretases. In particular, Aβ1-42 is the main component of the senile plaques associated with Alzheimers disease (AD). Glial cells participate in the uptake of soluble extra-cellular Aβ and in the clearance of this material at localized sites where the Aβ are concentrated. It has been shown that clusterin (Apo J) and apolipoprotein E (ApoE) exert important additive effects in reducing Aβ deposition. In agreement with the fact that homocysteine (Hcy) potentiates Aβ peptide neurotoxicity, and Hcy brain levels increase with age, it has been demonstrated that high plasma levels of Hcy are a risk factor for AD. In the present paper, we used animals subjected to chronic intake of methionine (1 g/kg/day) in the drinking water, since this treatment can increase plasma Hcy levels by 30%. By means of this animal model, interactions between the Aβ β- sheet rich fibrils and clusterin, have been evaluated in striata of animals after Aβ injection. Furthermore, it has been demonstrated that Aβ peptides are not only signals capable of activating astrocytes but also capable of reducing tyrosinehydroxylase immunoreactivity in the basal ganglia probably leading to a reduction of volume transmission. These alterations in the neuroglial network morphology and function can, at least in part, explain the enhanced pain threshold observed in the Aβ intra-striatally injected animals.
Keywords: Homocysteine, clusterin, β-amyloid, pain, neuroglial network, TH, GFAP, rat
Current Alzheimer Research
Title: Hyper-Homocysteinemia Alters Amyloid Peptide-Clusterin Interactions and Neuroglial Network Morphology and Function in the Caudate After Intrastriatal Injection of Amyloid Peptides
Volume: 4 Issue: 3
Author(s): Giuseppina Leo, Susanna Genedani, Monica Filaferro, Chiara Carone, Norma Andreoli, Serenella Astancolle, Pierpaolo Davalli, Kjell Fuxe and Luigi F. Agnati
Affiliation:
Keywords: Homocysteine, clusterin, β-amyloid, pain, neuroglial network, TH, GFAP, rat
Abstract: Amyloid peptides (Aβ) are fragments of the Amyloid Precursor Protein (APP), an integral membrane protein. Aβ peptides are continuously generated by neurons and non-neuronal cells via sequential cleavage of APP by secretases. In particular, Aβ1-42 is the main component of the senile plaques associated with Alzheimers disease (AD). Glial cells participate in the uptake of soluble extra-cellular Aβ and in the clearance of this material at localized sites where the Aβ are concentrated. It has been shown that clusterin (Apo J) and apolipoprotein E (ApoE) exert important additive effects in reducing Aβ deposition. In agreement with the fact that homocysteine (Hcy) potentiates Aβ peptide neurotoxicity, and Hcy brain levels increase with age, it has been demonstrated that high plasma levels of Hcy are a risk factor for AD. In the present paper, we used animals subjected to chronic intake of methionine (1 g/kg/day) in the drinking water, since this treatment can increase plasma Hcy levels by 30%. By means of this animal model, interactions between the Aβ β- sheet rich fibrils and clusterin, have been evaluated in striata of animals after Aβ injection. Furthermore, it has been demonstrated that Aβ peptides are not only signals capable of activating astrocytes but also capable of reducing tyrosinehydroxylase immunoreactivity in the basal ganglia probably leading to a reduction of volume transmission. These alterations in the neuroglial network morphology and function can, at least in part, explain the enhanced pain threshold observed in the Aβ intra-striatally injected animals.
Export Options
About this article
Cite this article as:
Giuseppina Leo , Susanna Genedani , Monica Filaferro , Chiara Carone , Norma Andreoli , Serenella Astancolle , Pierpaolo Davalli , Kjell Fuxe and Luigi F. Agnati , Hyper-Homocysteinemia Alters Amyloid Peptide-Clusterin Interactions and Neuroglial Network Morphology and Function in the Caudate After Intrastriatal Injection of Amyloid Peptides, Current Alzheimer Research 2007; 4 (3) . https://dx.doi.org/10.2174/156720507781077223
DOI https://dx.doi.org/10.2174/156720507781077223 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
Call for Papers in Thematic Issues
New Advances in the Prevention, Diagnosis, Treatment, and Rehabilitation of Alzheimer's Disease
Aims and Scope: Introduction: Alzheimer's disease (AD) poses a significant global health challenge, with an increasing prevalence that demands concerted efforts to advance our understanding and strategies for prevention, diagnosis, treatment, and rehabilitation. This thematic issue aims to bring together cutting-edge research and innovative approaches from multidisciplinary perspectives to address ...read more
Current updates on the Role of Neuroinflammation in Neurodegenerative Disorders
Neuroinflammation is an invariable hallmark of chronic and acute neurodegenerative disorders and has long been considered a potential drug target for Alzheimer?s disease (AD) and dementia. Significant evidence of inflammatory processes as a feature of AD is provided by the presence of inflammatory markers in plasma, CSF and postmortem brain ...read more
Deep Learning for Advancing Alzheimer's Disease Research
Alzheimer's disease (AD) poses a significant global health challenge, with an increasing number of individuals affected yearly. Deep learning, a subfield of artificial intelligence, has shown immense potential in various domains, including healthcare. This thematic issue of Current Alzheimer Research explores the application of deep learning techniques in advancing our ...read more
Diagnostic and therapeutic biomarkers of dementia
Dementia affects 18 million people worldwide. Dementia is a syndrome of symptoms caused by brain disease, usually chronic or progressive, clinically characterized by multiple impairments of higher cortical functions such as memory, thinking, orientation, and learning. In addition, in the course of dementia, cognitive deficits are observed, which often hinder ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Involvement of Trace Elements in the Pathogenesis of Prion Diseases
Current Pharmaceutical Biotechnology Perioperative Considerations in Diabetic Patients
Current Diabetes Reviews Inflammatory Process in Parkinsons Disease: Role for Cytokines
Current Pharmaceutical Design Editorial (Thematic Issue: Effective and Promising Treatments for Neurological Disorders and Cancer)
Current Pharmaceutical Design Lipid Alterations in the Earliest Clinically Recognizable Stage of Alzheimers Disease: Implication of the Role of Lipids in the Pathogenesis of Alzheimers Disease
Current Alzheimer Research Cytochrome P450 Drug Metabolizing Enzymes in Roma Population Samples: Systematic Review of the Literature
Current Medicinal Chemistry Hypothalamic Insulin-Sensitizing Effect of Exenatide in Dietary Induced Rat Model of Obesity
Current Drug Therapy mTOR: A Novel Therapeutic Target for Diseases of Multiple Systems
Current Drug Targets Progranulin Mutations in Ubiquitin-Positive Frontotemporal Dementia Linked to Chromosome 17q21
Current Alzheimer Research Recent Advances in Pathophysiology of Traumatic Brain Injury
Current Neuropharmacology Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer’s Disease
Current Neuropharmacology Artery of Percheron Infarction: A Characteristic Pattern of Ischemia and Variable Clinical Presentation: A Literature Review
Current Medical Imaging α-Lipoic Acid Supplementation: A Tool for Obesity Therapy?
Current Pharmaceutical Design BACE Inhibitors as Potential Drugs for the Treatment of Alzheimers Disease: Focus on Bioactivity
Recent Patents on CNS Drug Discovery (Discontinued) Small Ruminant Lentiviruses and Human Immunodeficiency Virus: Cousins that Take a Long View
Current HIV Research Intracellular Accumulation of Toxic Turn Amyloid-β is Associated with Endoplasmic Reticulum Stress in Alzheimer’s Disease
Current Alzheimer Research Children with Chronic Kidney Disease and Hypertension: Could Hypertension Footprints be Early Biomarkers?
Current Hypertension Reviews STAT3 and Its Phosphorylation are Involved in HIV-1 Tat-Induced Transactivation of Glial Fibrillary Acidic Protein
Current HIV Research Pleiotropic Effects of Cathepsin D
Endocrine, Metabolic & Immune Disorders - Drug Targets Antitumoral Activity of Interferon-γ Involved in Impaired Immune Function in Cancer Patients
Current Drug Metabolism